Language
English
Publication Date
4-1-2025
Journal
Journal of Pediatric Gastroenterology and Nutrition
DOI
10.1002/jpn3.12462
PMID
39840645
PMCID
PMC11961318
PubMedCentral® Posted Date
4-1-2026
PubMedCentral® Full Text Version
Author MSS
Abstract
Pediatric cholestatic liver diseases are rare conditions that can result from multiple specific underlying etiologies. Among the most common etiologies of pediatric cholestatic liver diseases are biliary atresia, Alagille syndrome (ALGS), and inherited disorders of bile acid transport. These diseases are characterized by episodic or chronic unremitting cholestasis. Due to the chronicity of these conditions, it is imperative to optimize medical management to improve patient quality of life, provide nutritional support, and reduce bile acid toxicity in efforts to slow disease progression. Cholestatic liver diseases remain the leading cause of pediatric liver transplantation, as many underlying disease etiologies have no curative medical therapies. In the present review, we provide an update on the nutritional, medical, and surgical management of pediatric cholestatic liver diseases. As recent advances have occurred in the field with the addition of ileal bile acid transporter (IBAT) inhibitors, we also review the results from prospective clinical trials, including their strengths and limitations. While recent clinical trials have demonstrated improved pruritus using IBAT inhibitors in ALGS and progressive familial intrahepatic cholestasis, establishing medical therapies proven to slow disease progression remains an area of unmet need.
Keywords
Humans, Child, Alagille Syndrome, Cholestasis, Biliary Atresia, Cholestasis, Intrahepatic, Liver Transplantation, Bile Acids and Salts
Published Open-Access
yes
Recommended Citation
Mysore, Krupa R; Cheng, Katherine; Suri, Lakshmi Anandini; et al., "Recent Advances in the Management of Pediatric Cholestatic Liver Diseases" (2025). Faculty, Staff and Students Publications. 7566.
https://digitalcommons.library.tmc.edu/baylor_docs/7566